EUVIMEDOntdek EUVIMED
Open access · CC BY-NC-ND 4.0

Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience

Colin Powers iD, Brielle Corrente, Jennifer Joyce, William Stein, Shelly Polydor, Vikraman Gunabushanam iD, Ajai Khanna iD, Fernanda P Silveira iD, Ruy J Cruz iD

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70065 ↗

At a glance

Journal article in Clinical Transplantation, 2025. Written by Colin Powers and 8 co-authors. Institution: Gastro-Intestinal Rehabilitation and Transplant Center - GIRTC, Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh…. Major MEDLINE topics: COVID-19, Organ Transplantation, Transplant Recipients, SARS-CoV-2. 12 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Background

There has been significant concern about coronavirus disease 2019 (COVID‐19) among transplant recipients, particularly those who are highly immunosuppressed. Several studies have analyzed the impact of COVID‐19 on different solid organ transplant patients. However, few isolated case reports of COVID‐19 in intestinal and multivisceral transplant (ITx and MVTx) recipients are available in the literature. We report the first single‐center study evaluating the clinical course and outcome of COVID‐19 in ITx/MVTx recipients.

Methods

Adult patients (age ≥ 18 years) with confirmed cases of COVID‐19 between February 2020 and February 2024 were included in this study.

Results

Twelve of the 67 (17.9%) ITx/MVTx recipients followed at our center had COVID‐19. Seven patients (58%) were female, and the median age at diagnosis was 47 years (range: 31–68 years). The average time from transplantation to COVID‐19 was 89 months (range: 14–215 months). Nine patients (75%) required hospitalization; three of them were admitted to the intensive care unit (ICU) and required ventilator support. One patient had COVID‐19 on two different occasions. Treatment modalities consisted of monoclonal antibody treatment ( n = 5), of antiviral therapy ( n = 4), and steroid monotherapy ( n = 1). Three patients received combination therapy. Three patients (25%) developed irreversible respiratory failure and died after prolonged ventilator use.

Conclusions

Our data suggested a possible increase in the incidence of COVID‐19 in ITx and MVTx recipients with an unchanged mortality rate despite the use of vaccines and new therapeutic modalities. Further multicenter studies are needed to analyze the real impact of COVID‐19 on this unique population.

Subjects

MeSH terms (MEDLINE)

COVID-19Organ TransplantationTransplant RecipientsSARS-CoV-2HumansFemaleMaleMiddle AgedAdultAgedIntestinesRetrospective StudiesImmunosuppressive AgentsImmunocompromised Host

Author keywords

COVID‐19SARS‐CoV‐2immunosuppressionintestinal transplantationoutcometransplants

Substances

Immunosuppressive Agents

Authors and institutions

  • Gastro-Intestinal Rehabilitation and Transplant Center - GIRTC, Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID profiles: Colin Powers, Vikraman Gunabushanam, Ajai Khanna, Fernanda P Silveira, Ruy J Cruz

Cite

APA

Powers, C., Corrente, B., Joyce, J., Stein, W., Polydor, S., Gunabushanam, V., Khanna, A., Silveira, F. P., & Cruz, R. J. (2025). Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience. Clinical Transplantation. https://doi.org/10.1111/ctr.70065

Vancouver

Powers C, Corrente B, Joyce J, Stein W, Polydor S, Gunabushanam V, et al. Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience. Clinical Transplantation. 2025. doi:10.1111/ctr.70065

BibTeX
@article{Powers2025,
  author = {Powers, Colin and Corrente, Brielle and Joyce, Jennifer and Stein, William and Polydor, Shelly and Gunabushanam, Vikraman and Khanna, Ajai and Silveira, Fernanda P and Cruz, Ruy J},
  title = {Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70065}
}
Start for free →